Latest Breaking News On - டெங் யூஎ - Page 3 : comparemela.com
新华社丨春节后，他们继续留在家乡_经济 民生_湖南频道
hn.rednet.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hn.rednet.cn Daily Mail and Mail on Sunday newspapers.
春节后，他们继续留在家乡-中新网
chinanews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from chinanews.com Daily Mail and Mail on Sunday newspapers.
Chinese Biotherapeutics Firm Transcenta Bags $105 Million From Sequoia, LAV, and Others
Liya Su / Dec 24, 2020 04:45 PM / Business & Tech
Chinese global biotherapeutics company Transcenta Holding Limited, which had raised an undisclosed equity financing from China Capital Management in June this year, said on Wednesday that it has garnered $105 million in a crossover financing led by China Structural Reform Fund.
The latest round attracted a slew of new investors including Qatar Investment Authority, Chinese property developer Country Garden Venture Capital, and others.
Existing backers Sequoia Capital China, life science-focused Lilly Asia Ventures (LAV), China Merchants Capital’s sub-fund CCT China Merchants Fund, and Teng Yue Partners also joined the round, the investee said in a statement.
Transcenta Holding Limited, a global biotherapeutics company with integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, completed a 105m USD crossover financing.
China Structural Reform Fund led the financing round, participated by new investors including Country Garden Venture Capital, Qatar Investment Authority, and other prominent institutional investors. Existing investors including CCT China Merchants Fund, Lilly Asia Ventures, Teng Yue Partners, Sequoia Capital China and others also participated in this round.
The proceeds from new funding will be used to accelerate ongoing clinical programs and prepare for commercialization.
Led by Dr. Jonathan Y. Zhao, Co-Founder and Chairman, and Dr. Xueming Qian, Co-Founder and CEO, Transcenta is a global biotherapeutics company that fully integrates antibody-based biotherapeutics discovery, development and manufacturing. Transcenta has established global footprint with Discovery and
Chinese biotherapeutics firm Transcenta bags $105m from Sequoia, LAV, others Premium
Chinese global biotherapeutics company Transcenta Holding Limited, which had raised an undisclosed equity financing from China Capital Management in June this year, said on Wednesday that it has garnered $105 million in a crossover financing led by China Structural Reform Fund.
Continue reading this story with a subscription to DealStreetAsia.
Contact us for corporate subscriptions at subs@dealstreetasia.com.
Sign up for our newsletter - The Daily Brief Opt out of receiving The Daily Brief in your inbox everyday
REGISTER stories left placeholder You have one free story left this month.
vimarsana © 2020. All Rights Reserved.